Magnetic resonance spectroscopy in vivo: Applications in neurological disorders

Neurological Sciences

Volumn 18, Issue 6, 1997, Pages 321-329

  Arnold, D L ^a   De Stefane, N ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Brain; Magnetic resonance spectroscopy; Muscle; Phosphorus; Proton

Indexed keywords

PHOSPHORUS; PROTON;

BRAIN; BRAIN TUMOR; HUMAN; METABOLISM; METHODOLOGY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE VALUE; REVIEW; SKELETAL MUSCLE;

BRAIN; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE, SKELETAL; NERVOUS SYSTEM DISEASES; PHOSPHORUS; PROTONS; REFERENCE VALUES;

EID: 0031299357     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02048235     Document Type: Article

References (47)

1. 31P MRS study. NMR Biomed., 1996; 9: 165-172.
2. ARGOV Z, DE STEFANO N, TAIVASSALO T, SRIPATHI A, KARPATI G, ARNOLD DL. Abnormal oxidative matabolism in exercise intolerance of undetermined origin. Neuromuscul Disord, 1997; 7: 99-104.
3. 31P NMR. Magn. Reson. Med., 1984; 1: 307-3'15.
4. ARNOLD DL, TAYLOR DJ, RADDA GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann. Neurol, 1985; 18: 189-196.
5. ARNOLD DL, MATTHEWS PM, FRANCIS G, ANTEL J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med., 1990; 14: 154-159.
6. ARNOLD DL. MATTHEWS PM, FRANCIS GS, O'CONNOR J, ANTEL JP. Proton Magnetic Resonance Spectroscopic Imaging for Metabolic Characterization of Demyel inciting Plaques. Ann. Neurol., 1992; 31: 235-241.
7. ARNOLD DL, MATTHEWS PM, DE STEFANO N. MRI and proton MRS in the evaluation of multiple sclerosis. In: Bachelard, eds. Magnetic resonance spectroscopy and imaging in neurochemistry. New York: Plenum Press. 1997; 8: 267-288.
8. ARNOLD DL, MATTHEWS PM. Clinical applications of brain magnetic resonance spectroscopy. In: IR Young, C Charles, eds. MR Spectroscopy: Clinical Applications and Techniques. London: Martin Dunitz. 1995.
9. CENDES F, ANDERMANN F, PREUL MC, ARNOLD DL. Lateralisation of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann. Neurol., 1994; 35: 211-216.
10. CENDES F, ANDERMANN F, DUBEAU F, ARNOLD DL. Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy. Magn. Reson. Imaging, 1995a; 13: 1187-1191.
11. CENDES F, ANDERMANN F, SILVER K, ARNOLD DL. Imaging of axonal damage in vivo in Rasmussen's syndrome. Brain, 1995b; 118: 753-758.
12. CENDES F, STANLEY JA, DUBEAU F, ANDERMANN F, ARNOLD DL. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann. Neurol., 1997; 41: 74-81.
13. DAVIE CA, HAWKINS CP, BARKER GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain, 1994; 117: 49-58.
14. DE STEFANO N, GENGE A, KARPATI G, MATTHEWS PM, ARNOLD DL. Improvement of cerebral metabolism in patients with mitochondrial disorders bv Dichloroacetate (DCA) treatment. Neurology, 1995; 45: l 193-1198.
15. DE STEFANO N, MATTHEWS PM, ANTEL JP, PREUL M, FRANCIS G, ARNOLD DL. Chemical-pathology of acute demyelinating lesion and its correlation with disability. Ann. Neurol., 1995; 38: 901-909.
16. DE STEFANO N, ARGOV Z, MATTHEWS PM, KARPATI G, ARNOLD DL. Impairement of mitochondrial oxidative metabolism in McArdle's disease. Muscle & Nerve, 1996; 19: 764-769.
17. DE STEFANO N. MATTHEWS PM, NARAYANAN S, FRANCIS GS, ANTEL JP, ARNOLD DL. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology, 1997; 49 (4): 1138-1141.
18. DE STEFANO N, PREUL M, CARAMANOS Z, FRANCIS GS, ANDEL JP, ARNOLD DL. Differentiation between brain tumors and giant demyelinating lesions in vivo using proton magnetic resonance spectroscopic imaging. Neurology, 1997b; 48: A360-A361.
19. DE STEFANO N. MATTHEWS PM, ARNOLD DL. Reversible decreases in N-acetylaspartate following acute brain injury. Mag Res Med, 1995; 34: 721-727.
20. Fu L, MATTHEWS PM, DE STEFANO N, et al. Imaging axonal damage of normal appearing white matter in multiple sclerosis. Brain, 1998; In Press.
21. 31P and 1H spectroscopic imaging. Ann. Neurol., 1994; 36: 157-165.
22. 2 relaxometry. Neurology, 1993:43: 1793-1799.
23. JACKSON GD. KCZNIECKI RI, CASCINO GD. Hippocampal sclerosis without detectable hippocampal atrophy. Neurology, 1994: 44: 42-46.
24. KWO-ON-YUEN PF, NEWMARK RD, BUDINGER TF, KAYE JA, BALL MJ, JAGUST WJ. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Res., 1994; 667: 167-174.
25. LOSSEFF NA, WANG L, LAI HM, et al. Progressive cerebral atrophv in multiple sclerosis. A serial MRI study. Brain, 1996; 119: 2009-2019.
26. LOSSEFF NA, WEBB SL, O'RIORDAN JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain, 1996; 119: 701-708.
27. MATTHEWS PM, ANDERMANN F, ARNOLD DL. A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology, 1990; 40: 985-989.
28. MATTHEWS PM, ALLAIRE C, SHOUBRIDGE EA, KARPATI G, CARPENTER S, ARNOLD DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology, 1991; 41: 114-120.
29. MATTHEWS PM. FRANCIS G, ANTEL J, ARNOLD DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis[published erratum appears in Neurology 1991 Nov;4l(H):1828]. Nemology, 1991; 41: 1251-1256.
30. MATTHEWS PM, ANDERMANN F, SILVER K, KARPATI G, ARNOLD DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyapathies. Neurology, 1993; 43: 2484-2490.
31. MCDONALD WI. Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis. [Review]. J. Neuropathol Exp. Neurol., 1994; 53: 338-343.
32. MENON DK, AINSWORTH JG, Cox IJ, et al. Proton MR spectroscopy of the brain in AIDS dementia complex. J. Comput. Assist. Tomogr., 1992; 16: 538-542.
33. MILLER DH, ALBERT PS, BARKHOF F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann. Neurol., 1996; 39: 6-16.
34. MOFFETT JR, NAMBOODIRI MAA, CANGRO CB, NEALE JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport, 1991; 2: 131-134.
35. NARAYANAN S, Fu L, PIORO E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann. Neurol., 1997; 41:385-391.
36. PATY DW, Li DK, OGER JJ, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann. Neurol., 1994; 36 Suppl: S95-6.
37. PIORO EP, ANTEL JP, CASHMAN NR, ARNOLD DL. Detection of cortical neuronal loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology, 1994; 44: 1933-1938.
38. PREUL M, CARAMANOS Z, COLLINS DL, et al. Accurate,noninvasive diagnosis of human brain tumor by using proton magnetic resonance spectroscopy, Nat. Med., 1996; 2: 323-325.
39. RADDA GK, BORE PJ, RAJAGOPALAN B. Clinical aspects of 31P NMR spectroscopy. Br. Med. J., 1984; 40; 155-159.
40. Ross B, KREIS R, ERNST T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. [Review]. Eur. J. Radiol., 1992; 14: 128-140.
41. Ross BD, RADDA GK, GADIAN DG, ROCKER G, ESIRI M, FALCONER-SMITH J. Examination of a case of suspected McArdle's svndrome by 31P nuclear magnetic resonance. N. Engl. J. Med.. 1981; 304: 1338-1342.
42. SIMMONS ML, FRONDOZA CG, COYLE JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience, 1991; 45: 37-45.
43. TAIVASSALO T. MATTHEWS PM, DE STEFANO N, et al. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cvtochrome oxidase deficiency. Neurology, 1996; 47: 529-534.
44. TAYLOR DJ, BORE PJ, STYLES P, GADIAN DG, RADDA GK. Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med, 1983; 1: 77-94.
45. TEDESCHI G. SCHIFFMANN R, BARTON NW, et al. Proton magnetic resonance spectroscopy imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology, 1995; 45: 1526-1532.
46. TSAI GC, COYLE JT. N-Acetylaspartate in neuropsychiatrie disorders [Review]. Progr Neurobiol, 1995; 46: 531-540.
47. WOLINSKY JS. NARAYANAN PA, FENSTERMACHER MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology, 1990; 40: 1764-1769.